Preeclampsia in Pregnant Women Suffering Hyperlipidemia.
Conditions
Interventions
Intervention 1: Intervention group: From the first month to the end of pregnancy for 9 months, the intervention group receives omega-3 daily as one gram capsule containing eicosapentalenoic acid and d
Sponsors
Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Pregnant Women Suffering Hyperlipidemia that triglyceride levels is above 150 Milligrams per Deciliter.
Exclusion criteria
Exclusion criteria: Pregnant women that are suffering metabolic diseases. Pregnant women that have the age of less than 20 years and over the age of 40 years. Pregnant women that have a history of preeclampsia in a previous pregnancy or in a first-degree relative. Pregnant women that have a history of having twins. Pregnant women that have a body mass index equal to or greater than 29. Pregnant women that have kidney disease, high blood pressure, diabetes and hyperthyroidism. Pregnant women that use of aspirin, calcium, anticoagulants and insulin. Pregnant women that do not have history of omega-3 allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preeclampsia. Timepoint: Before the intervention in the first month of pregnancy and 9 months after the intervention in the last month of pregnancy. Method of measurement: Blood pressure above 140 to 90 mm Hg, swelling of the hands and face, overweight, based on the results of clinical trials of the patient's blood, including protein in the urine, increased liver enzymes, decreased platelet count, increased creatine and ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Mahdavian Naghash Zargar
Kurdistan University of Medical Sciences
Outcome results
None listed